Company Filing History:
Years Active: 1988-1989
Title: The Innovations of Dieter Angersbach
Introduction
Dieter Angersbach is a notable inventor based in Gronau, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of various vascular and cognitive disorders. With a total of two patents to his name, Angersbach's work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Angersbach's latest patents include innovative compounds such as di/tetra-hydroquinolines, which are designed for the treatment of hypertension in mammals, including humans. These compounds are defined in detail in the specifications of his patents. Additionally, he has developed a novel treatment method for cerebral vascular and neuronal degenerative disorders. This method addresses issues related to learning, memory, and cognitive dysfunctions, including conditions like multi-infarct dementia and Alzheimer's disease. The treatment involves administering an effective amount of 1,3-di-n-butyl-7-(2-oxypropyl) xanthine or a pharmaceutically acceptable salt thereof to those in need.
Career Highlights
Throughout his career, Angersbach has worked with reputable companies such as Beecham-Wuelfing GmbH & Co. KG and Beecham Group Plc. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.
Collaborations
Angersbach has collaborated with notable professionals in his field, including Charles D. Nicholson and Joachim E. Goring. These collaborations have likely enriched his research and development efforts, leading to the successful patents he holds today.
Conclusion
Dieter Angersbach's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving health outcomes for individuals with vascular and cognitive disorders. His work continues to pave the way for advancements in medical treatments.